|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-6-13
|
|
pubmed:abstractText |
To determine the risk of bronchopulmonary dysplasia (BPD) in subgroups of infants with and without patent ductus arteriosus (PDA) who were randomized to indomethacin prophylaxis or placebo, and to examine whether adverse drug effects on edema formation and oxygenation may explain why indomethacin prophylaxis does not reduce BPD.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0022-3476
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
148
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
730-734
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16769377-Bronchopulmonary Dysplasia,
pubmed-meshheading:16769377-Cyclooxygenase Inhibitors,
pubmed-meshheading:16769377-Ductus Arteriosus, Patent,
pubmed-meshheading:16769377-Humans,
pubmed-meshheading:16769377-Indomethacin,
pubmed-meshheading:16769377-Infant, Newborn,
pubmed-meshheading:16769377-Infant, Premature,
pubmed-meshheading:16769377-Infant, Very Low Birth Weight,
pubmed-meshheading:16769377-Logistic Models,
pubmed-meshheading:16769377-Randomized Controlled Trials as Topic,
pubmed-meshheading:16769377-Risk,
pubmed-meshheading:16769377-Urine
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP).
|
|
pubmed:affiliation |
Department of Pediatrics and Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada. schmidt@mcmaster.ca
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
